VYTORIN 10/10MG TABLET

국가: 말레이시아

언어: 영어

출처: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

지금 구매하세요

환자 정보 전단 환자 정보 전단 (PIL)
24-06-2019
제품 특성 요약 제품 특성 요약 (SPC)
24-06-2019

유효 성분:

SIMVASTATIN; EZETIMIBE

제공처:

MERCK SHARP & DOHME (MALAYSIA) SDN BHD

INN (International Name):

SIMVASTATIN; EZETIMIBE

패키지 단위:

10Tablet Tablets; 30Tablet Tablets

Manufactured by:

MSD International GmbH (Singapore Branch)

환자 정보 전단

                                _Consumer Medication Information Leaflet (RiMUP)_
VYTORIN
®
Ezetimibe/Simvastatin (10mg/10mg, 10mg/20mg, 10mg/40mg, 10mg/80mg)
1
WHAT IS IN THIS LEAFLET
1.
What VYTORIN is used for
2.
How VYTORIN works
3.
Before you use VYTORIN
4.
How to use VYTORIN
5.
While you are using it
6.
Side effects
7.
Storage and disposal of
VYTORIN
8.
Product description
9.
Manufacturer and product
registration holder
10.
Date of revision
11.
Serial number
Please read this information
carefully before you start to take
your medicine, even if you have
just refilled your prescription.
Some of the information may have
changed. You should also read any
information provided with other
medicines you are currently taking.
Remember that your doctor has
prescribed this medicine only for
you. Never give it to anyone else.
WHAT VYTORIN IS USED FOR
VYTORIN (ezetimibe/simvastatin)
is a tablet that is available in four
strengths:
−
VYTORIN 10/10 (ezetimibe
10 mg/simvastatin 10 mg)
−
VYTORIN 10/20 (ezetimibe
10 mg/simvastatin 20 mg)
−
VYTORIN 10/40 (ezetimibe
10 mg/simvastatin 40 mg)
−
VYTORIN 10/80 (ezetimibe
10 mg/simvastatin 80 mg)
VYTORIN is a medicine used to
lower levels of total cholesterol,
LDL (bad) cholesterol, and fatty
substances called triglycerides in
the blood. In addition, VYTORIN
raises levels of HDL (good)
cholesterol. VYTORIN is for
patients who cannot control their
cholesterol levels by diet alone.
You should stay on a cholesterol-
lowering diet while taking this
medicine.
If you have heart disease,
VYTORIN reduces the risk of
heart attack, stroke, surgery to
increase heart blood flow, or
hospitalization for chest pain.
WHY HAS MY DOCTOR PRESCRIBED
VYTORIN?
Your doctor has prescribed
VYTORIN to reduce the amount
of cholesterol and triglycerides in
your blood. Cholesterol is one of
several fatty substances found in
the bloodstream. Your total
cholesterol is made up mainly of
LDL and HDL cholesterol.
LDL cholesterol is often called
“bad” cholesterol because it can
build up in the walls of your
arteries forming plaque. Ev
                                
                                전체 문서 읽기
                                
                            

제품 특성 요약

                                VYTORIN
(ezetimibe/simvastatin)
LPC	-MK0653A	-T-122018	-Malaysia
LOCAL PRODUCT CIRCULAR
Tablets
VYTOR	IN	® 10/10
(EZETIMIBE 10 MG/SIM	VASTATIN 10	MG)
VYTORIN	® 10/20
(EZETIMIBE 10 MG/SIM	VASTATIN 20	MG)
VYTORIN	® 10/40
(EZETIMIBE 10 MG/SIM	VASTATIN 40	MG)
VYTO	RIN	® 10/80
(EZETIMIBE 10 MG/SIM	VASTATIN 80	MG)
I. THERAPEUTIC CLASS
VYTORIN	(ezetimibe/simvastatin) is a lipid	-lowering product that selectively inhibits the intestinal
absorption of cholesterol and related plant sterols and inhibits the endogenous syn	thesis of
cholesterol.
II. COMPOSITION
VYTORIN is available for or	al use as tablets containing 10 mg of ezetimibe, and 10	mg of
simvastatin (	VYTORIN	10/10), 20	mg of simvastatin (	VYTORIN 10/20), 40	mg of simvastatin
(VYTORIN 10/40), or 80	mg of simvast	atin (	VYTORIN 10/80).
III. CLINICAL PHARMACOLOGY
IIIa. Mechanism of Acti	on
VYTORIN
Plasma cholesterol is derived from intestinal absorption and endogenous synthesis.	VYTORIN
contains ezetimibe and simvastatin, two lipid	-lowering compounds with comp	lementary
mechanisms of action.	VYTORIN reduces	elevated total	-C, LDL	-C, Apo B, TG, and non	-HDL	-C,
and increases HDL	-C through dual inhibition of cholesterol absorption and synthesis	.
Ezetimibe
Ezetimibe inhibits the intestinal absorption of cholesterol.	Ezetimibe is orally active and has a
                                
                                전체 문서 읽기
                                
                            

다른 언어로 된 문서

환자 정보 전단 환자 정보 전단 말레이어 24-06-2019

이 제품과 관련된 검색 알림